LCM
RETA

Laurion Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Laurion Capital Management’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$1.24M Buy
2020
Q3 		– Sell
2020
Q2 		$1.35M Buy
2018
Q2 		– Sell
2018
Q1 		$3.31M Sell
2017
Q4 		$14.7M Buy